{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:37Z","timestamp":1791644437349,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ogun Ministry of Education Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nbt.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T17:11:52Z","timestamp":1739639512000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Efficient surface display of single-chain variable fragments against tumor necrosis factor \u03b1 on engineered probiotic Saccharomyces boulardii and its application in alleviating intestinal inflammation in vivo"],"prefix":"10.1016","volume":"86","author":[{"given":"Kanghee","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongsoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1756283X11428502","article-title":"Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders","volume":"5","author":"Kelesidis","year":"2012","journal-title":"Ther Adv Gastroenter"},{"key":"10.1016\/j.nbt.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00203-009-0491-x","article-title":"Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties","volume":"191","author":"Martins","year":"2009","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.nbt.2025.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30426","article-title":"The preventive effects of Saccharomyces boulardii against oxidative stress induced by lipopolysaccharide in rat brain","volume":"10","author":"Babaei","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nbt.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.2510100403","article-title":"Disposition kinetics of Saccharomyces boulardii in man and rat","volume":"10","author":"Blehaut","year":"1989","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.nbt.2025.02.003_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.794742","article-title":"Yeast surface display system: strategies for improvement and biotechnological applications","volume":"9","author":"Teymennet-Ram\u00edrez","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nbt.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41598-017-00414-2","article-title":"Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii","volume":"7","author":"Khatri","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2025.02.003_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112660","article-title":"Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii","volume":"9","author":"Hudson","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.nbt.2025.02.003_bib8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.4014\/jmb.2305.05019","article-title":"Development of a novel ATP bioluminescence assay based on engineered probiotic Saccharomyces boulardii expressing firefly luciferase","volume":"33","author":"Park","year":"2023","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.nbt.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fgb.2013.11.006","article-title":"The establishment of Saccharomyces boulardii surface display system using a single expression vector","volume":"64","author":"Wang","year":"2014","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.nbt.2025.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105458","article-title":"Surface display of pancreatic lipase inhibitor peptides by engineered Saccharomyces boulardii: potential as an anti-obesity probiotic","volume":"102","author":"Nayebhashemi","year":"2023","journal-title":"J Funct Foods"},{"key":"10.1016\/j.nbt.2025.02.003_bib11","doi-asserted-by":"crossref","unstructured":"Shin J., Jin Y.S., Kim S.R. Engineering Saccharomyces boulardii for cell surface display of heterologous protein. 2023;PREPRINT (Version 1) available at Research Square. https:\/\/doi.org\/10.21203\/rs.3.rs-3229997\/v1.","DOI":"10.21203\/rs.3.rs-3229997\/v1"},{"key":"10.1016\/j.nbt.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/antib2020193","article-title":"In vivo applications of single chain Fv (variable domain) (scFv) fragments","volume":"2","author":"Monnier","year":"2013","journal-title":"Antibodies"},{"key":"10.1016\/j.nbt.2025.02.003_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12026-015-8667-8","article-title":"A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides","volume":"62","author":"Geng","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.nbt.2025.02.003_bib14","unstructured":"Bong K.T. Production of recombinant antibodies against tumor necrosis factor alpha in recombinant Escherichia coli: Seoul National University; 2006."},{"key":"10.1016\/j.nbt.2025.02.003_bib15","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/ijms20081887","article-title":"Tumour necrosis factor alpha in intestinal homeostasis and gut related diseases","volume":"20","author":"Ruder","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nbt.2025.02.003_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gendis.2020.02.004","article-title":"Therapeutic potential of TNF\u03b1 inhibitors in chronic inflammatory disorders: past and future","volume":"8","author":"Zhang","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.nbt.2025.02.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nbt.2025.02.003_bib18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AEM.00057-16","article-title":"Metabolic engineering of probiotic Saccharomyces boulardii","volume":"82","author":"Liu","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.nbt.2025.02.003_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.biortech.2016.12.042","article-title":"Bioethanol production from cellulosic hydrolysates by engineered industrial Saccharomyces cerevisiae","volume":"228","author":"Lee","year":"2017","journal-title":"Bioresour Technol"},{"key":"10.1016\/j.nbt.2025.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodcont.2022.109236","article-title":"Direct and efficient elimination of ethyl carbamate by engineered Saccharomyces cerevisiae displaying urethanase","volume":"142","author":"Han","year":"2022","journal-title":"Food Control"},{"key":"10.1016\/j.nbt.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1016\/j.nbt.2025.02.003_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201544","article-title":"A biomarker-responsive nanosystem with colon-targeted delivery for ulcerative colitis's detection and treatment with optoacoustic\/NIR-II fluorescence imaging","volume":"11","author":"Zeng","year":"2022","journal-title":"Adv Health Mater"},{"key":"10.1016\/j.nbt.2025.02.003_bib23","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1021\/acsnano.0c01018","article-title":"Nanoparticles derived from the natural antioxidant rosmarinic acid ameliorate acute inflammatory bowel disease","volume":"14","author":"Chung","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.nbt.2025.02.003_bib24","article-title":"Extracellular ATP mediates inflammatory responses in colitis via P2 x 7 receptor signaling","volume":"6","author":"Wan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12934-021-01617-z","article-title":"Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up","volume":"20","author":"Madhavan","year":"2021","journal-title":"Micro Cell Fact"},{"key":"10.1016\/j.nbt.2025.02.003_bib26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/yea.1806","article-title":"Characterization of different promoters for designing a new expression vector in Saccharomyces cerevisiae","volume":"27","author":"Partow","year":"2010","journal-title":"Yeast"},{"key":"10.1016\/j.nbt.2025.02.003_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202200398","article-title":"Efficient production of glutathione in Saccharomyces cerevisiae via a synthetic isozyme system","volume":"18","author":"Jeon","year":"2023","journal-title":"Biotechnol J"},{"key":"10.1016\/j.nbt.2025.02.003_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymben.2015.02.004","article-title":"Enhanced tolerance of Saccharomyces cerevisiae to multiple lignocellulose-derived inhibitors through modulation of spermidine contents","volume":"29","author":"Kim","year":"2015","journal-title":"Metab Eng"},{"key":"10.1016\/j.nbt.2025.02.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biortech.2022.128556","article-title":"Systematic engineering of Saccharomyces cerevisiae for efficient synthesis of hemoglobins and myoglobins","volume":"370","author":"Xue","year":"2023","journal-title":"Bioresour Technol"},{"key":"10.1016\/j.nbt.2025.02.003_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1567-1364.2012.00810.x","article-title":"Metabolic engineering of recombinant protein secretion by Saccharomyces cerevisiae","volume":"12","author":"Hou","year":"2012","journal-title":"Fems Yeast Res"},{"key":"10.1016\/j.nbt.2025.02.003_bib31","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/bit.26008","article-title":"Enhanced cell-surface display and secretory production of cellulolytic enzymes with Sed1 signal peptide","volume":"113","author":"Inokuma","year":"2016","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nbt.2025.02.003_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12934-021-01644-w","article-title":"Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory","volume":"20","author":"Jin","year":"2021","journal-title":"Micro Cell Fact"},{"key":"10.1016\/j.nbt.2025.02.003_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nbt0697-553","article-title":"Yeast surface display for screening combinatorial polypeptide libraries","volume":"15","author":"Boder","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nbt.2025.02.003_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12934-019-1133-x","article-title":"Development of novel surface display platforms for anchoring heterologous proteins in Saccharomyces cerevisiae","volume":"18","author":"Yang","year":"2019","journal-title":"Micro Cell Fact"},{"key":"10.1016\/j.nbt.2025.02.003_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/intimm\/dxu051","article-title":"Pleiotropic functions of TNF-alpha in the regulation of the intestinal epithelial response to inflammation","volume":"26","author":"Leppkes","year":"2014","journal-title":"Int Immunol"},{"key":"10.1016\/j.nbt.2025.02.003_bib36","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.4049\/jimmunol.1700350","article-title":"The stimulation of macrophages with TLR ligands supports increased IL-19 expression in inflammatory bowel disease patients and in colitis models","volume":"199","author":"Steinert","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.nbt.2025.02.003_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/clpt.2011.328","article-title":"Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms","volume":"91","author":"Ordas","year":"2012","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.nbt.2025.02.003_bib38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","article-title":"Mechanism of action of anti-TNF therapy in inflammatory bowel disease","volume":"10","author":"Levin","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.nbt.2025.02.003_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biomaterials.2019.05.012","article-title":"Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis","volume":"212","author":"Gou","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.nbt.2025.02.003_bib40","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.7150\/thno.47601","article-title":"Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.nbt.2025.02.003_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12896-019-0518-6","article-title":"Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice","volume":"19","author":"Chiabai","year":"2019","journal-title":"BMC Biotechnol"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678425000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678425000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:23:06Z","timestamp":1742343786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678425000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"alternative-id":["S1871678425000196"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2025.02.003","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient surface display of single-chain variable fragments against tumor necrosis factor \u03b1 on engineered probiotic Saccharomyces boulardii and its application in alleviating intestinal inflammation in vivo","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}